Log in
Enquire now
‌

US Patent 7709605 ActRII receptor polypeptides, methods and compositions

Patent 7709605 was granted and assigned to Acceleron Pharma on May, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Acceleron Pharma
Acceleron Pharma
0
Date Filed
July 25, 2005
0
Date of Patent
May 4, 2010
0
Patent Application Number
11190202
0
Patent Citations Received
‌
US Patent 12071456 Extended recombinant polypeptides and compositions comprising same
0
‌
US Patent 11884715 Activin receptor type IIB variants and methods of use thereof
0
‌
US Patent 11890321 Method of treating or inhibiting glucose intolerance
0
‌
US Patent 11981744 Chimeric polypeptide assembly and methods of making and using the same
0
‌
US Patent 12024563 ALK7 antagonists and uses thereof
0
‌
US Patent 11685770 Stabilized receptor polypeptides and uses thereof
0
‌
US Patent 11713358 Chimeric polypeptide assembly and methods of making and using the same
0
Patent Inventor Names
John Knopf
0
Jasbir Seehra
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7709605
0
Patent Primary Examiner
‌
Sean E Aeder
0

Find more entities like US Patent 7709605 ActRII receptor polypeptides, methods and compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.